Response to combination therapy of HCV 3a infected Pakistani patients and the role of NS5A protein

BACKGROUND: Hepatitis C virus (HCV) genotype 3a is known to show comparatively better response to combination therapy than genotype 1 and 4. Mutations within NS5A gene of HCV have earlier been implicated with response to interferon (IFN) therapies in chronic HCV patients among various populations. A...

Descripción completa

Detalles Bibliográficos
Autores principales: Ali, Ijaz, Khan, Sanaullah, Attaullah, Sobia, Khan, Shahid Niaz, Khan, Jabbar, Siraj, Sami, Iqbal, Aqib, Swati, Zahoor A, Idrees, Muhammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3118205/
https://www.ncbi.nlm.nih.gov/pubmed/21609495
http://dx.doi.org/10.1186/1743-422X-8-258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3118205/
https://www.ncbi.nlm.nih.gov/pubmed/21609495
http://dx.doi.org/10.1186/1743-422X-8-258

Ejemplares similares